Filing Details

Accession Number:
0000711377-19-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-24 18:09:53
Reporting Period:
2019-01-22
Accepted Time:
2019-01-24 18:09:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-22 25,334 $40.46 761,818 No 4 M Direct
Coommon Stock Disposition 2019-01-22 25,334 $60.01 736,484 No 4 S Direct
Common Stock Disposition 2019-01-22 10,000 $60.24 726,484 No 4 S Direct
Common Stock Disposition 2019-01-22 10,000 $60.00 403,035 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (right to Buy) Disposition 2019-01-22 25,334 $0.00 25,334 $40.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
276,767 2021-10-29 No 4 M Direct
Footnotes
  1. Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  2. These shares were sold out of a charitable remainder trust in which Mr. Herbert and his spouse are beneficiaries and trustees; 98,783 shares remain in the trust. An additional 144,280 shares are held in trust for Mr. Herbert's spouse. The remaining shares are held in limited liability companies in which Mr. Herbert and his spouse have minority financial position.